This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

EU Pharmaceutical Law Forum
Hybrid Event
20-22 May, 2025Steigenberger Wiltcher's, Brussels
Hybrid Event
20-22 May, 2025,
Steigenberger Wiltcher's, Brussels

Tuesday 20 May 2025

Authority Insights, Practical Commercial Guidance and Interactive Debate on Antitrust Challenges and Recent Developments for Patents & SPCs

Dive In To Key Competition Law, SPC, and Patient Litigation Perspectives On:

Expert Insight from Antitrust Authorities

  • Exclusive insight on authority approach and review pharmaceutical merger control cases
  • Be armed for negotiations on discriminatory pricing, discounts and rebates
  • Analyze the legal fallout and changes needed in working practices from the Servier case

Practical Advice on Managing Antitrust Risk

  • Examine commercial implications of merger control activity
  • Avoid risk in information exchange between competitors
  • Gain visibility on how FSR is operating and how it will affect your organization

Prepare for Changes to Patents & SPCs and Discover How:

  • EU-wide compulsory licensing instruments affect your Regulatory Data Protection
  • SPC revisions to patent protection in the EU Pharma package will impact your business
  • Litigation is being affected by the Unified Patent Court (UPC)